PCI Pharma Services-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PCI Pharma Services - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013920
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PCI Pharma Services (PCI) is a drug development company that offers clinical manufacturing and packaging solutions. The company offers clinical services such as pharmaceutical development, clinical trial manufacturing, clinical trial packaging, clinical supplies management, clinical planning support and biological derivatives. It also provides commercial services including commercial manufacturing, contained manufacturing, commercial packaging, qualified persons and serialization. PCI’s support services include analytical and laboratory services, warehousing and gmp storage, logistics, and others. The company operates in the US, UK and Japan. PCI is headquartered in Philadelphia, Pennsylvania, the US.

PCI Pharma Services – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PCI Pharma Services, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PCI Pharma Services, Medical Devices Deals, 2011 to YTD 2017 9
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PCI Pharma Services, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Partners Group to Acquire PCI Pharma Services from Frazier Healthcare Ventures 11
Acquisition 12
Packaging Coordinators Acquires Biotec Services 12
Packaging Coordinators Completes Acquisition of Penn Pharma 13
PCI Pharma Services – Key Competitors 14
PCI Pharma Services – Key Employees 15
PCI Pharma Services – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Oct 19, 2017: Molecule to Market: PCI Affirms Position as Market-Leading Pharmaceutical Outsourcing Provider 17
Aug 07, 2017: PCI Pharma Services: FastTrack Service Launch 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
PCI Pharma Services, Pharmaceuticals & Healthcare, Key Facts 2
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PCI Pharma Services, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PCI Pharma Services, Deals By Therapy Area, 2011 to YTD 2017 8
PCI Pharma Services, Medical Devices Deals, 2011 to YTD 2017 9
PCI Pharma Services, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Partners Group to Acquire PCI Pharma Services from Frazier Healthcare Ventures 11
Packaging Coordinators Acquires Biotec Services 12
Packaging Coordinators Completes Acquisition of Penn Pharma 13
PCI Pharma Services, Key Competitors 14
PCI Pharma Services, Key Employees 15
PCI Pharma Services, Other Locations 16

★海外企業調査レポート[PCI Pharma Services-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TransForce Inc.:企業のM&A・事業提携・投資動向
    TransForce Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransForce Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Braskem SA (BRKM5):企業の財務・戦略的SWOT分析
    Braskem SA (BRKM5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Odebrecht SA:企業の戦略的SWOT分析
    Odebrecht SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • EPAM Systems Inc (EPAM):企業の財務・戦略的SWOT分析
    EPAM Systems Inc (EPAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • The Bank of Kyoto Ltd:企業の戦略・SWOT・財務情報
    The Bank of Kyoto Ltd - Strategy, SWOT and Corporate Finance Report Summary The Bank of Kyoto Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Providence Resources Plc (PZQA):石油・ガス:M&Aディール及び事業提携情報
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Fabric Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalon …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • Deutsche Borse AG:企業の戦略・SWOT・財務情報
    Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Avisa Pharma Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic di …
  • SVB Financial Group:企業のM&A・事業提携・投資動向
    SVB Financial Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SVB Financial Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • ImmuCell Corp (ICCC):企業の財務・戦略的SWOT分析
    ImmuCell Corp (ICCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Steel Authority of India Ltd:企業のM&A・事業提携・投資動向
    Steel Authority of India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Steel Authority of India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • McGill University:製薬・医療:M&Aディール及び事業提携情報
    Summary McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, e …
  • OSE Immunotherapeutics (OSE):企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆